BROSSARD, QUEBEC, CANADA--(Marketwire - June 29, 2011) - DIAGNOS inc. ("DIAGNOS" or "the Corporation")(TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announces that, on June 27th, 2011, the Board of Directors has approved a grant of 500,000 stock options to its directors under the terms of the share stock option plan of the Corporation approved by the Shareholders in September 2008.
The exercise price has been established at $0.30 per share. The expiry date where these options can be exercised has been fixed to June 26th, 2016.
About DIAGNOS
Founded in 1998, DIAGNOS is a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including natural resources, healthcare, and entertainment.
For further information, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release.
Contact Information:
President
1-877-678-8882 or (450) 678-8882, ext.: 224
alarente@diagnos.com